Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
The process of introducing a new medication to the market, starting from initial development to the final launch, is both time-intensive and heavily regulated, often spanning over a decade or more. Achieving success in this endeavor hinges on the timely availability of precise analytical data, which is essential for making informed decisions during the early stages of development and reducing the likelihood of setbacks later on. Modern drug development primarily follows a systematic approach, with the crucial first step usually being the identification of a biological target to concentrate efforts on. This target identification demands a comprehensive understanding of the characteristics of the candidates, enabling swift and reliable identification of the most promising options. After establishing a biological target, the next significant hurdle is identifying the most advantageous lead molecules, which entails discovering potential drug candidates—these may include small organic compounds or biological constructs with therapeutic capabilities. Thus, the entire journey from concept to market is a complex interplay of scientific insight and strategic decision-making.
Description
Nanome serves as an interactive platform designed for collaborative molecular visualization and the exploration of drug discovery. Users can upload protein and small-molecule structures to examine together in a three-dimensional format, accessible through a web browser or various XR headsets such as the Meta Quest 3 and 3S, Apple Vision Pro, and Samsung Galaxy XR. In a shared session, all participants, including a chemist using a headset and a peer working from a laptop, can simultaneously focus on the same molecular feature, no matter their physical locations. The platform incorporates MARA, an AI copilot that efficiently performs docking, co-folding, electrostatics calculations, and ADMET predictions based on straightforward, natural language inputs, utilizing over 300 integrated scientific tools to provide 3D models for further examination. Additionally, Nanome supports a variety of file formats including PDB, mmCIF, SDF, MOL2, PyMOL, and Maestro, while also offering connectivity to platforms like Schrodinger LiveDesign, OpenEye, Cresset Flare, CDD Vault, KNIME, and Jupyter. For enterprises, deployment options include single-tenant or on-premises setups, enhancing security and control. A free web seat is available, along with a 14-day complete trial that requires no credit card for access. Overall, Nanome is revolutionizing how teams collaborate in the field of molecular science.
API Access
Has API
No
API Access
Has API
No
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
$20.83/month/user (academic)
Free Trial
Yes
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
Yes
iPhone App
No
iPad App
No
Android App
No
Windows
Yes
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
No
Webinars
Yes
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
Bruker
Founded
1960
Country
United States
Website
www.bruker.com/en/applications/pharma/drug-discovery.html
Vendor Details
Company Name
Nanome
Founded
2015
Country
United States
Website
nanome.ai
Product Features
Product Features
Alternatives
Alternatives
No Alternatives